Joinn Laboratories (06127) appoints Luo Xi and Gu Jingliang as executive directors.
Chao Yan New Drug (06127) announced the appointment of Ms. Luo Xi and Mr. Gu Jingliang as executive directors; ...
Joinn Laboratories (06127) announces the appointment of the following: (i) Ms. Luo Xi and Mr. Gu Jingliang as executive directors; (ii) Mr. Yang Fuquan, Mr. Yang Changyun, and Mr. Ying Fangtian as independent non-executive directors, effective from the conclusion of the extraordinary general meeting. In addition, from the date of the conclusion of the extraordinary general meeting, (i) Ms. Sun Yunxia will be appointed as a member of the company's remuneration and assessment committee and strategic committee; (ii) Ms. Luo Xi will be appointed as a member of the strategic committee; (iii) Mr. Yang Fuquan will be appointed as the chairman of the company's nomination committee and a member of the audit committee; (iv) Mr. Yang Changyun will be appointed as the chairman of the audit committee and a member of the remuneration and assessment committee; and (v) Mr. Ying Fangtian will be appointed as the chairman of the remuneration and assessment committee and a member of the strategic committee and nomination committee.
Related Articles

ByteDance launches Seed3D 1.0, a tool for creating large-scale 3D models from a single image, achieving simulation-grade quality.

Sinolink: Maintains a "buy" rating for POP MART (09992), optimistic about the continuation of high-quality development in the Chinese market.

Tengda Construction Group (600512.SH): Consortium wins bid for major project worth 469 million yuan.
ByteDance launches Seed3D 1.0, a tool for creating large-scale 3D models from a single image, achieving simulation-grade quality.

Sinolink: Maintains a "buy" rating for POP MART (09992), optimistic about the continuation of high-quality development in the Chinese market.

Tengda Construction Group (600512.SH): Consortium wins bid for major project worth 469 million yuan.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025